RAPT Therapeutics Inc Sustainability Reports
RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing oral small molecule and monoclonal antibody therapies for patients with significant unmet needs in inflammatory diseases and oncology.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300MB473BIU78ES48
4 reports from 2019 to 2023